drugset

drugset / Trial / NCT00004423

Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease

NCT00004423 ↗

Completed 80 enrolled University of Vermont

RandomizedTreatment

Summary

OBJECTIVES: I. Assess the efficacy and safety of 4-aminosalicylic acid in patients with active Crohn's disease of the small bowel.

Timeline

Start: 1995-12
Primary completion: —
Completion: 1998-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	4-Aminosalicylic acid	Unknown	—	Oral

Indications